Skip to main content

Table 3 Result of simple regresssion analysis for detected oral streptococci

From: The significance of oral streptococci in patients with pneumonia with risk factors for aspiration: the bacterial floral analysis of 16S ribosomal RNA gene using bronchoalveolar lavage fluid

   b SE (b)  β p-value
Age >80 13.92 4.47 0.229 0.002
BMI<20 −4.07 2.89 −0.106 0.161
Hospitalization for >2 days in the preceding 90 day; n (%) 4.15 4.63 0.068 0.371
Residence in a nursing home or long-term care facility 14.48 5.49 0.196 0.009
Home infusion therapy (including antibiotics) 9.88 7.26 0.102 0.170
ECOG PS of premorbid condition>3 23.37 4.87 0.341 <0.001
COPD −0.28 5.60 −0.004 0.960
Interstitial pneumonia 0.18 7.92 0.002 0.982
Lung cancer −0.16 9.55 −0.001 0.987
Bronchiectasis −6.63 7.28 −0.069 0.364
Cerebrovascular disease 7.75 5.85 0.100 0.187
Neuromuscular diseases 8.62 7.09 0.092 0.226
Dementia 8.14 6.20 0.099 0.191
Gastroesophageal disorder 5.72 6.12 0.705 0.351
Pharyngeal disorder 19.48 11.22 0.130 0.084
Presence of the risk factor for aspiration 12.78 4.31 0.219 0.004
Malignancy excluding lung cancer −1.73 5.10 −0.026 0.735
Psychiatric disease 1.68 12.18 0.010 0.891
Sleeping medications 10.24 6.08 0.126 0.094
Antipsychotic drugs −4.94 10.61 −0.035 0.642
Antidepressant 10.40 10.01 0.078 0.300
History of pneumonia within the previous 1 year 16.12 4.92 0.241 0.001
Albumin<4 g/dl −3.25 6.56 −0.037 0.621
Bilateral lung involvement 0.01 4.37 0.0002 0.998
Lower lobe opacity −4.67 4.40 −0.08 0.291
Posterior dominant opacity 4.56 4.87 0.071 0.351
Gravity-dependent opacity −7.52 5.27 −0.107 0.155
  1. Definition of abbreviations: BMI body mass index, ECOG PS eastern cooperative oncology group performance status, HCAP healthcare-associated pneumonia, COPD chronic obstructive pulmonary disease